Clinical Trials Directory

Trials / Sponsors / OSE Immunotherapeutics

OSE Immunotherapeutics

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingTrial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistan
Patients With Non-Small Cell Lung Cancer
Phase 32024-12-03
RecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
Phase 1 / Phase 22022-12-20
UnknownTo Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults
Coronavirus Disease (COVID-19)
Phase 12021-05-26
CompletedStudy of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
Ulcerative Colitis
Phase 22020-10-02
CompletedA Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
Solid Tumor, Adult
Phase 12019-04-16
CompletedPhase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OS
Healthy Subjects
Phase 12018-12-19
TerminatedOSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor
Non Small Cell Lung Cancer
Phase 32016-02-12
CompletedSafety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104
Rheumatoid Arthritis, Complication of Transplant
Phase 12015-04-01